Spots Global Cancer Trial Database for biliary
Every month we try and update this database with for biliary cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Gemcitabine and Sorafenib in Advanced Biliary Tract Cancer (GEMSO) | NCT00661830 | Adenocarcinoma | Gemcitabine Placebo Sorafenib | 18 Years - | Johannes Gutenberg University Mainz | |
| Comparing Endoscopic Based Stent Strategy Versus Bypass Surgery in Non-resectable Periampullary Cancer | NCT00487851 | Pancreatic Neop... Biliary Tract N... Duodenal Neopla... | surgery endoscopic stra... | - | Karolinska Institutet | |
| A Multi-Center, Open-Label Study of Surufatinib (HMPL-012) in Patients With Advanced Solid Tumors | NCT02549937 | Tumors | surufatinib | 18 Years - | Hutchmed | |
| Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders | NCT01438385 | Ampullary Cance... Duodenal Cancer Bile Duct Cance... Bile Duct Disor... Gallstones Obstructive Jau... Pancreatic Diso... Colorectal Canc... Esophageal Canc... Barrett's Esoph... Gastric Maligna... Pancreatic Canc... Pediatric Gastr... Cholangiocarcin... Pancreatic Pseu... Acute and Chron... Recurrent Pancr... Cholangitis Bile Leak Biliary Strictu... Pancreatic Divi... Biliary and Pan... Choledocholithi... | Interventional ... | 18 Years - | Weill Medical College of Cornell University | |
| Study of Minnelide™ in Patients With Advanced GI Tumors | NCT01927965 | Advanced Gastro... | Minnelide™ 001 | 18 Years - | Minneamrita Therapeutics LLC | |
| Wet Heparinized Suction for Abdominal Cancer | NCT05041335 | Cancer of Pancr... Cancer of Stoma... Cancer of Esoph... Cancer of Liver Cancer | wet heparinzed ... Microsieve No heparin flus... No microsieve | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)-China Extension Study | NCT04924062 | Biliary Tract C... | Pembrolizumab Gemcitabine Cisplatin Placebo | 18 Years - | Merck Sharp & Dohme LLC | |
| A Study of FOLFOX6 With Bevacizumab for Biliary System Carcinoma | NCT00881504 | Biliary Tract C... | "Bevacizumab" i... | 18 Years - | Georgetown University | |
| A Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas | NCT01900158 | Cholangiocarcin... | Amphinex, Gemci... | 18 Years - | PCI Biotech AS | |
| Endoscopic Radiofrequency Ablation for Unresectable Cholangiocarcinoma | NCT06175845 | Cholangiocarcin... Klatskin Tumor Bile Duct Cance... Liver Cancer | Intraductal bil... | 18 Years - | Universitätsklinikum Hamburg-Eppendorf | |
| A Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas | NCT01900158 | Cholangiocarcin... | Amphinex, Gemci... | 18 Years - | PCI Biotech AS | |
| Single Agent Regorafenib in Refractory Advanced Biliary Cancers | NCT02115542 | Cancer of the B... | Regorafenib | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Covered Versus Uncovered SEMS for Palliation of Malignant Biliary Strictures. | NCT02930252 | Biliary Cancer | Niti-S Biliary ... Niti-S stent (D... | 18 Years - | Azienda USL 1 Imperiese | |
| A Study of FOLFOX6 With Bevacizumab for Biliary System Carcinoma | NCT00881504 | Biliary Tract C... | "Bevacizumab" i... | 18 Years - | Georgetown University | |
| Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966) | NCT04003636 | Biliary Tract C... | Pembrolizumab Gemcitabine Cisplatin Placebo | 18 Years - | Merck Sharp & Dohme LLC | |
| Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders | NCT01438385 | Ampullary Cance... Duodenal Cancer Bile Duct Cance... Bile Duct Disor... Gallstones Obstructive Jau... Pancreatic Diso... Colorectal Canc... Esophageal Canc... Barrett's Esoph... Gastric Maligna... Pancreatic Canc... Pediatric Gastr... Cholangiocarcin... Pancreatic Pseu... Acute and Chron... Recurrent Pancr... Cholangitis Bile Leak Biliary Strictu... Pancreatic Divi... Biliary and Pan... Choledocholithi... | Interventional ... | 18 Years - | Weill Medical College of Cornell University | |
| A Study of AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary Cancer | NCT02908451 | Gastric Cancer Colorectal Canc... Pancreatic Canc... Biliary Cancer | AbGn-107 | 18 Years - | AbGenomics B.V Taiwan Branch | |
| Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer | NCT00753675 | Biliary Tract C... Gallbladder Can... Cancer Of The E... Ampullary Carci... | ZD6474, Vandeta... ZD6474, Vandeta... Gemcitabine Placebo matchin... | 18 Years - | Sanofi | |
| Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966) | NCT04003636 | Biliary Tract C... | Pembrolizumab Gemcitabine Cisplatin Placebo | 18 Years - | Merck Sharp & Dohme LLC | |
| Cytoreductive Surgery(CRS) Plus Hyperthermic Intraoperative Peritoneal Chemotherapy(HIPC) With Cisplatin to Treat Peritoneal Carcinomatosis From Upper Gastrointestinal Cancer | NCT01116791 | Peritoneal Carc... Gastrointestina... | Cytoreductive S... | 18 Years - 75 Years | University Hospital, Gasthuisberg | |
| Study of the WallFlex™ Biliary Partially-covered Stent for the Palliative Treatment of Malignant Bile Duct Obstruction | NCT00713427 | Biliary Strictu... | WallFlex™ Bilia... | 18 Years - | Boston Scientific Corporation | |
| Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer | NCT00753675 | Biliary Tract C... Gallbladder Can... Cancer Of The E... Ampullary Carci... | ZD6474, Vandeta... ZD6474, Vandeta... Gemcitabine Placebo matchin... | 18 Years - | Sanofi | |
| A Study of FOLFOX6 With Bevacizumab for Biliary System Carcinoma | NCT00881504 | Biliary Tract C... | "Bevacizumab" i... | 18 Years - | Georgetown University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
